½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting



  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹KSR2¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹KSR2¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW11058
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·

    ÖÐÎÄÃû³Æ£º Íÿ¹KSR2¶à¿Ë¡¿¹Ìå

    Ó¢ÎÄÃû³Æ£º Anti-KSR2 rabbit polyclonal antibody

    Ïà¹ØÀà±ð£º Ò»¿¹

    ´¢     ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

    ¿¹     Ô­£º KSR2

    ËÞ     Ö÷£º Rabbit

    ·´Ó¦ÖÖÊô£º Human Mouse

    ±ê ¼Ç Î Unconjugate

    ¿Ë¡ÀàÐÍ£º Unconjugate

    ¼¼Êõ¹æ¸ñ

    Background:

    Location-regulated scaffold connecting MEK to RAF. Has very low protein kinase activity and can phosphorylate MAP2K1 at several Ser and Thr residues with very low efficiency (in vitro). Interaction with BRAF enhances KSR2-mediated phosphorylation of MAP2K1 (in vitro). Blocks MAP3K8 kinase activity and MAP3K8-mediated signaling. Acts as a negative regulator of MAP3K3-mediated activation of ERK, JNK and NF-kappa-B pathways, inhibiting MAP3K3-mediated interleukin-8 production.

    Applications:

    WB, IF

    Name of antibody:

    KSR2

    Immunogen:

    Synthesized peptide derived from internal of human KSR2.

    Full name:

    kinase suppressor of ras 2

    Synonyms£º

    0

    SwissProt:

    Q6VAB6

    WB Predicted band size:

    108 kDa

    WB Positive control:

    COS7,293,3T3 cell lysates

    WB Recommended dilution:

    500-3000

    IF positive control:

    Hela cells

    IF Recommend dilution:

    100-500









    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿